This article presents an overview of the 5 Best Foreign Stocks With Dividends. For a detailed overview of such stocks, read our article, 12 Best Foreign Stocks With Dividends.

5. Cenovus Energy Inc (NYSE:CVE)

Number of Hedge Fund Investors: 41

Yet another Canadian dividend stock in our list of the best foreign stocks with dividends, Cenovus Energy Inc (NYSE:CVE) came on the radar of Goldman Sachs earlier this month as the firm added the stock in its list of energy picks.

“We see opportunities to add exposure to high-quality stocks at attractive valuations, but also remain selective. We see an improved risk-reward post the recent pullback in crude and Morgan Stanley economists have an above-consensus view on 2024 growth,” Morgan Stanley’s Devin McDermott said in a note.

L1 Long Short Fund made the following comment about Cenovus Energy Inc. (NYSE:CVE) in its Q3 2023 investor letter:

“Cenovus Energy Inc. (NYSE:CVE) (Long +23%) shares rallied as WTI oil prices rose to ~US$91/bbl over the month, the highest level since November 2022. The company also had tailwinds from higher refinery margins, particularly in North America which remains their key exposure. Cenovus continues to generate strong free cash flow at current oil price levels, with the long-life nature of its oil sands assets and its low cost of production providing a break-even oil price at around ~US$40/bbl. We estimate the company can reach its net debt target in early CY24, enabling a step-up in shareholder returns through on-market share buybacks.”

4. GSK plc (NYSE:GSK)

Number of Hedge Fund Investors: 42

British pharma giant GSK plc (NYSE:GSK) ranks 4th in our list of the best foreign stocks with dividends. In November GSK plc (NYSE:GSK) increased its sales forecast for Arexvy vaccine for respiratory syncytial virus (RSV). Overall, GSK plc’s (NYSE:GSK) pipeline looks healthy, with 67 drugs in clinical development.

As of the end of the third quarter of 2023, 42 hedge funds tracked by Insider Monkey had stakes in GSK plc (NYSE:GSK).

Ariel Global Fund made the following comment about GSK plc (NYSE:GSK) in its Q3 2023 investor letter:

“Global pharmaceutical and healthcare company, GSK plc (NYSE:GSK), also advanced in the period following a top- and bottom-line earnings beat and subsequent raise in full-year guidance. Shares were also aided by a successful U.S. and European launch of Arexvy, a respiratory syncytial virus (RSV) vaccine for older adults. Although risks around the Zantac litigation remain a concern, we believe GSK should generate sustainable growth and margin expansion as the company transitions its Pharma pipeline towards specialty medicines and vaccines. Furthermore, the company’s robust balance sheet provides the scope for bolt-ons, which has the potential to drive additional growth.”

3. CRH PLC (NYSE:CRH)

Number of Hedge Fund Investors: 48

Building materials company CRH PLC (NYSE:CRH) is one of the top dividend stocks.

CRH PLC’s (NYSE:CRH) CEO Albert Manifold talked about CRH PLC’s (NYSE:CRH) dividend policy and other updates during Q3 earnings call:

“Total group sales of $26.3 billion were 8% ahead, reflecting good underlying demand and further commercial progress across our businesses. This translates into EBITDA of $4.8 billion, 14% ahead and a further 100 basis points of margin improvement, a strong performance despite [containing] but some inflationary cost pressures. This morning, we’ve announced an agreement to acquire an attractive portfolio cement and readymix concrete assets in Texas for $2.1 billion, a significant investment which will deliver further growth and value creation for our shareholders. I’ll take you through that in further a little later presentation. We also continue to return significant amounts of cash to our shareholders through dividends and share buybacks. Our ongoing share buyback program is on track to return approximately $3 billion in 2023 and the current tranche of the program will be completed before the end of the year.

In advance of our indented transition to quarterly dividends in 2024 and consistent with our progressive dividend policy and strong financial position, this morning, we have announced an accelerated payment of our 2023 dividend, representing a 5% increase compared to the prior year. Looking ahead to the remainder of the year and based on current trading conditions at the momentum we see across our businesses, I’m pleased to report that we are raising our previous guidance and expect to deliver full year group EBITDA of approximately $6.3 billion well ahead of the prior year and representing another record year for CRH.”

Read the entire earnings call transcript here.

Here is what Voss Capital has to say about CRH plc (NYSE:CRH) in its Q3 2023 investor letter:

“While the market has recently been focused on GPU chips and AI scripts, our attention has been on cement blocks and crushed rocks. We’ve enthusiastically made CRH one of our largest positions ever at cost due to its limited downside. CRH is among the largest aggregates and infrastructure companies in the United States and Europe and has recently relisted to the NYSE from the LSE, which we believe will be a catalyst for the stock to rerate upwards towards peer valuations as its undeniable value hiding in plain sight becomes more widely discussed.

In 1970, Cement Limited and Roadstone Limited, two Irish infrastructure-focused companies, combined to form Cement and Roadstone Holdings, or “CRH.” An investment of $1 million into CRH upon its founding since that fateful merger ~53 years ago would have turned into ~$1.5 billion by mid-year 2023, an annualized total return to investors of 15.0%, a high rate of compounding we think can continue.

Half a century of success at CRH has been driven by disciplined operations and capital allocation that we believe derives from a company culture built around appropriate financial incentives. CRH’s M&A playbook has proven to be successful as an acquisitive company like CRH can’t compound at a rate of 15% over 50 years unless acquisitions and divestitures have been executed at attractive prices. Over the last five years, CRH has spent $10.3 billion on acquisitions while receiving $10.5 billion in proceeds from divestitures across dozens of transactions, with the average acquisition multiple ranging from 7x – 8x EBITDA depending on the year and the average exit multiple clocking in at 11x EBITDA.”

2. Shell PLC (NYSE:SHEL)

Number of Hedge Fund Investors: 49

London-based oil giant Shell PLC (NYSE:SHEL) ranks 2nd in our list of the best foreign stocks with dividends.

A total of 49 hedge funds in Insider Monkey’s database had stakes in Shell PLC (NYSE:SHEL). The biggest stake in Shell PLC (NYSE:SHEL) is owned by Ken Fisher’s Fisher Asset Management which owns a $1.4 billion stake in Shell PLC (NYSE:SHEL).

1. AstraZeneca plc (NASDAQ:AZN)

Number of Hedge Fund Investors: 49

AstraZeneca plc (NASDAQ:AZN) is making waves after the company said it would buy U.S. vaccine developer Icosavax (NASDAQ:ICVX) for $1.1 billion. The deal is part of AstraZeneca plc’s (NASDAQ:AZN) plans to strengthen its respiratory syncytial virus (RSV) vaccine portfolio.

Of the 910 hedge funds in Insider Monkey’s database, 49 funds had stakes in AstraZeneca plc (NASDAQ:AZN).

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below. You can also look at the 11 Best Foreign Stocks To Buy Now and the Centi-Billionaire Bill Gates’ Top 15 Dividend Stocks.